nonhormonal การใช้

• The ad makes it clear that Fosamax is a nonhormonal treatment.
• Pregnancy may also influence autoimmune risk through entirely nonhormonal means.
• Both hormonal and nonhormonal factors may influence a woman's susceptibility to acne.
• Some get help from other nonhormonal drugs, though none work as well as estrogen.
• The nonhormonal portion of the prohormone is thought to be the urotensin binding protein ( urophysin ).
• The makers of nonhormonal drugs that treat osteoporosis are also trying to take advantage of the Prempro study.
• The panel advised women concerned about bone loss to consult their doctors about nonhormonal ways to prevent it.
• Various treatments, including estrogen and the popular nonhormonal drug Fosamax, can slow bone loss by targeting osteoclasts.
• The study is the first to document that the nonhormonal bone-building drug prevents fractures significant enough to cause symptoms.
• The new FDA approval could help millions of women and offer a nonhormonal option for osteoporosis prevention, the company said.
• And fewer than 2 percent of the physicians discussed such nonhormonal therapies as diet, exercise, stress reduction and smoking cessation.
• Nonhormonal options for temporary relief of vaginal dryness include gels or creams like Replens, Vagisil, Astroglide and K-Y jelly.
• It's a drug called alendronate, which researchers say is the first nonhormonal medication that not only reduces bone loss but adds new healthy bone mass.
• Drugs to lower cholesterol and blood pressure are better for reducing the risk of heart disease for many women, and other nonhormonal drugs work better in preventing fractures.
• Among the increasingly common nonhormonal contributors to acne is physical stress, especially friction from clothing or the wearing of tight clothes, like exercise tights, that keep the skin from breathing normally.
• An advisory committee unanimously recommended the U . S . Food and Drug Administration approve the drug, which would become the first nonhormonal treatment for the nation's 20 million osteoporosis patients.
• Estrogen-replacement therapy and a new nonhormonal drug called alendronate each reduce the risk of hip fractures in people with osteoporosis by 51 percent, according to findings announced last month by the University of California at San Francisco.
• A more ground-breaking drug, Merck & AMP; Co .'s Fosamax, is poised to become the nation's first nonhormonal treatment for osteoporosis, preventing bone loss by binding to the cells that attack bone.
• AT RISK : A simple questionnaire designed to identify postmenopausal women at increased risk of osteoporosis is available through Merck & AMP; Co ., the pharmaceutical company that makes and markets alendronate, the first nonhormonal drug approved to prevent bone loss and rebuild bone mass.